Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine

由 Xue, Hui Yi, Liu, Shimeng, Wong, Ho Lun
出版 2014

A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy

由 Xue, Hui Yi, Tran, Ngoc, Wong, Ho Lun
發表在 Eur J Pharm Biopharm (2016)

Nanomedicine applications in the treatment of breast cancer: current state of the art

由 Wu, Di, Si, Mengjie, Xue, Hui-Yi, Wong, Ho-Lun
發表在 Int J Nanomedicine (2017)

Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions

由 Narvekar, Mayuri, Xue, Hui Yi, Eoh, June Young, Wong, Ho Lun
出版 2014

Lipid-Based Nanocarriers for RNA Delivery

由 Xue, Hui Yi, Guo, Pengbo, Wen, Wu-Cheng, Wong, Ho Lun
發表在 Curr Pharm Des (2015)

Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms

由 Guo, Pengbo, Buttaro, Bettina A, Xue, Hui Yi, Tran, Ngoc T, Wong, Ho Lun
發表在 Eur J Pharm Biopharm (2020)

Manuscript for International Journal of Pharmaceutics Enhanced eradication of intracellular and biofilm-residing methicillin-resistant: Staphylococcus aureus (MRSA) reservoirs with...

由 Guo, Pengbo, Xue, Hui Yi, Buttaro, Bettina A, Tran, Ngoc T, Wong, Ho Lun
發表在 Int J Pharm (2020)

Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain

由 Guo, Pengbo, Si, Mengjie, Wu, Di, Xue, Hui Yi, Hu, Wenhui, Wong, Ho Lun
發表在 J Control Release (2020)

Nanomedicine of synergistic drug combinations for cancer therapy – strategies and perspectives

由 Zhang, Rui Xue, Wong, Ho Lun, Xue, Hui Yi, Eoh, June Young, Wu, Xiao Yu
發表在 J Control Release (2016)